Delving into the Latest Updates on Green Cross China Biological Products Co., Ltd. with Synapse

Overview

Tags

Congenital Disorders

Other Diseases

Nervous System Diseases

Enzyme

Non-recombinant coagulation factor

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Endocrinology and Metabolic Disease	1
Hemic and Lymphatic Diseases	1
Nervous System Diseases	1

Top 5 Drug Type	Count

Non-recombinant coagulation factor	1
Enzyme	1

Top 5 Target	Count

GAG(Glycosaminoglycan)	1
Fibrinogen	1

1) Through a simple PK study of a single dose, explore some key pharmacokinetic (PK) characteristics of this product to provide a basis for the dosage calculation of this product; 2) Evaluate the efficacy and safety of this product in the treatment of patients with congenital fibrinogen deficiency or deficiency after marketing.

Start Date-

Sponsor / Collaborator

Green Cross China Biological Products Co., Ltd.

CTR20180860 / Not yet recruitingPhase 3

评价静注人免疫球蛋白(pH4)治疗原发免疫性血小板减少症有效性和安全性的临床研究

[Translation] Clinical study to evaluate the efficacy and safety of intravenous human immunoglobulin (pH4) in the treatment of primary immune thrombocytopenia

以原生产工艺静注人免疫球蛋白(pH4)对照，评价静注人免疫球蛋白(pH4)治疗原发免疫性血小板减少症的有效性和安全性。

[Translation]

To evaluate the efficacy and safety of intravenous human immunoglobulin (pH4) in the treatment of primary immune thrombocytopenia, using the original production process of intravenous human immunoglobulin (pH4) as a control.

Start Date-

Sponsor / Collaborator

Green Cross China Biological Products Co., Ltd.

100 Clinical Results associated with Green Cross China Biological Products Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Green Cross China Biological Products Co., Ltd.

Login to view more data

100 Deals associated with Green Cross China Biological Products Co., Ltd.

Login to view more data

100 Translational Medicine associated with Green Cross China Biological Products Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

2

Login to view more data